Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8683614 | Epilepsy & Behavior | 2018 | 6 Pages |
Abstract
Drug-sensitive behavioral domains and items were identified which qualify for a self-report screening tool. The tool indicates impairments with a higher drug load and when administering AEDs with negative psychotropic profiles. The next steps require normalization in healthy subjects and the clinical validation of the newly developed screening tool PsyTrack along with antiepileptic drug treatment.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Lea Julia Mertens, Juri-Alexander Witt, Christoph Helmstaedter,